Glover Nicholas
Insider CIK 1578888 · LITS Director · DNAI CEO and President, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LITS Lite Strategy, Inc. | A Award deriv | 2026-10-22 | 2026-10-26 | 100,000 | — | $0 | 100,000 | SEC↗ |
| LITS Lite Strategy, Inc. | A Award deriv | 2025-11-14 | 2025-11-19 | 55,000 | — | $0 | 55,000 | SEC↗ |
| LITS Lite Strategy, Inc. | P Buy | 2025-07-23 | 2026-10-26 | 1,000 | $6.00 | $6.0K | 2,000 | SEC↗ |
| LITS Lite Strategy, Inc. | P Buy | 2025-07-22 | 2026-10-26 | 1,000 | $6.55 | $6.5K | 1,000 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2025-07-15 | 2025-07-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2023-09-29 | 2023-10-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2022-07-05 | 2022-07-07 | 87,500 | — | $0 | 87,500 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2021-07-01 | 2021-07-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2020-07-02 | 2020-07-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2020-02-25 | 2020-02-27 | 359,158 | — | $0 | 359,158 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2019-07-01 | 2019-07-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2019-03-04 | 2019-03-05 | 607,500 | — | $0 | 607,500 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2018-07-12 | 2018-07-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2018-03-06 | 2018-03-07 | 562,780 | — | $0 | 562,780 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2017-07-06 | 2017-07-10 | 40,000 | — | $0 | 118,793 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2017-03-06 | 2017-03-08 | 195,000 | — | $0 | 195,000 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | A Award deriv | 2016-09-30 | 2016-10-04 | 500,000 | — | $0 | 500,000 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2016-07-29 | 2016-08-01 | 40,000 | — | $0 | 78,793 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | A Award deriv | 2016-03-08 | 2016-03-10 | 161,250 | — | $0 | 161,250 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | M Exercise deriv | 2016-01-15 | 2016-01-19 | 5,000 | — | $0 | 864,219 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | S Sale | 2016-01-15 | 2016-01-19 | 5,000 | $10.04 | $50.2K | 0 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | M Exercise | 2016-01-15 | 2016-01-19 | 5,000 | $0.97 | $4.8K | 5,000 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2015-07-28 | 2015-07-29 | 20,000 | — | $0 | 38,793 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2014-07-14 | 2014-07-16 | 8,000 | — | $0 | 18,793 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2013-07-15 | 2013-07-17 | 6,730 | — | $0 | 10,793 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2013-06-07 | 2013-06-11 | 4,063 | — | $0 | 4,063 | SEC↗ |